| Literature DB >> 29540575 |
Valentin Blanchard1,2, Stéphane Ramin-Mangata2, Stéphanie Billon-Crossouard1,3, Audrey Aguesse1,3, Manon Durand1,4, Kevin Chemello2, Brice Nativel2, Laurent Flet5, Maud Chétiveaux1, David Jacobi4,6, Jean-Marie Bard1,7, Khadija Ouguerram1,3, Gilles Lambert2, Michel Krempf1,3,6, Mikaël Croyal8,3.
Abstract
Human apoE exhibits three major isoforms (apoE2, apoE3, and apoE4) corresponding to polymorphism in the APOE gene. Total plasma apoE concentrations are closely related to these isoforms, but the underlying mechanisms are unknown. We aimed to describe the kinetics of apoE individual isoforms to explore the mechanisms for variable total apoE plasma concentrations. We used LC-MS/MS to discriminate between isoforms by identifying specific peptide sequences in subjects (three E2/E3, three E3/E3, and three E3/E4 phenotypes) who received a primed constant infusion of 2H3-leucine for 14 h. apoE concentrations and leucine enrichments were measured hourly in plasma. Concentrations of apoE2 were higher than apoE3, and concentrations of apoE4 were lower than apoE3. There was no difference between apoE3 and apoE4 catabolic rates and between apoE2 and apoE3 production rates (PRs), but apoE2 catabolic rates and apoE4 PRs were lower. The mechanisms leading to the difference in total plasma apoE concentrations are therefore related to contrasted kinetics of the isoforms. Production or catabolic rates are differently affected according to the specific isoforms. On these grounds, studies on the regulation of the involved biochemical pathways and the impact of pathological environments are now warranted.Entities:
Keywords: lipoprotein/kinetics; lipoprotein/metabolism; liquid chromatography; peptide; stable isotope tracers; tandem mass spectrometry
Mesh:
Substances:
Year: 2018 PMID: 29540575 PMCID: PMC5928431 DOI: 10.1194/jlr.P083576
Source DB: PubMed Journal: J Lipid Res ISSN: 0022-2275 Impact factor: 5.922